The safety profile of GLP-1 injections is well-established, with many individuals experiencing minimal side effects
doi: 10.1172/jci.insight.164921
Products sold as powders in vials that need mixing are not authorised and carry critical health challenges
Efficacy: Patients undergoing bariatric surgery often achieve a loss of 25% to 35% of their total body weight, with long-term maintenance being more common than with medication or diet alone
Reducing carbohydrate intake, increasing protein, cycling caloric intake, or implementing time-restricted eating windows can break through metabolic adaptation
In the 64-week OASIS 4 trial (307 adults), mean weight loss was 13.6% under the treatment-policy analysis and 16.6% among participants who stayed on treatment, versus about 2% on placebo